Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated

World Journal of Gastroenterology

Volumn 11, Issue 30, 2005, Pages 4703-4708

  Lin, Xu ^a   Xu, Xiao ^a   Huang, Qing Ling ^a   Liu, Yu Qing ^b   Zheng, Da Li ^a   Chen, Wan Nan ^a   Lin, Jian Yin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genotype; Hepatitis B virus; Mutation; X gene

Indexed keywords

BETA GALACTOSIDASE; HEPATITIS B VIRUS X PROTEIN; HYGROMYCIN; LIPOFECTAMINE; METHANOL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CALCULATION; CELL CULTURE; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXPRESSION VECTOR; GENE MUTATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GIEMSA STAIN; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STUDENT T TEST; TRANSACTIVATION;

EID: 23844445641     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i30.4703     Document Type: Article

References (27)

1. Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous trasncriptional activator. J Med Viol 1992; 36: 101-117
2. Feitelson MA. Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 1999; 181: 188-202
3. Vieth S, Manegold C, Drosten C, Nippraschk T, Gunther S. Sequence and phylogenetic analysis of hepatits B virus genotype G isolated in Germany. Virus Gene 2002; 24: 153-156
4. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83(Pt 8): 2059-2073
5. Ding X, Mizokami M, Yao G, Xu B, Orito E, Ueda R, Nakanishi M. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001; 44: 43-47
6. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-334
7. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S. A case control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001; 33: 218-223
8. Gunther S. Naturally occurring mutations of hepatitis B virus and outcome of chronic infection: is there an association? Eur J Clin Invest 2000; 30: 751-753
9. Lin X, Xu X, Huang QL, Zheng DL, Lin JY. Difference in structural and transactivating capacity between X proteins of genotype B and C hepatitis B virus. Zhonghua Weishengwuxue He Mianyixue Zazhi 2004; 24: 559-563
10. Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999; 52: 25-137
11. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999; 18: 4848-4859
12. Assogba BD, Choi BH, Rho HM. Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-kappaB site. Virus Res 2002; 84: 171-179
13. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37: 19-26
14. Caselmann WH, Koshy R. Transactivators of HBV, signal transduction and tumorigenesis In: Caselmann WH and Koshy R eds. Hepatitis B Virus: Molecular Mechanisms in Disease and Novel Strategies for Therapy, London: Imperial College Press 1998: 161-181
15. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC. Hepatitis B virus, X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94: 14707-14712
16. Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998; 273: 33347-33353
17. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320
18. Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 1999; 31: 123-132
19. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastrol Hepatol 2002; 17: 643-650
20. Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology 2000; 31: 1037-1044
21. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143: 2313-2326
22. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus, X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999; 18: 4848-4859
23. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61: 7803-7810
24. Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines. Oncogene 1999; 18: 2860-2871
25. Soussan P, Garreau F, Zylberberg H, Ferray C, Brechot C, Kremsdorf D. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000; 105: 55-60
26. Xu X, Chen WN, Zheng DL, Huang QL, Lin X. X protein variations of genotype B and C hepatitis B virus isolated from the patients with hepatocellular carcinama. Aizheng 2004; 23: 756-761
27. Rapicetta M, Ferrari C, Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 2002; 67: 454-457